United States Women Health Laboratory Testing Market By Hereditary Cancer (Cervical Cancer, Ovarian Cancer, Breast Cancer), By Reproductive Health and Infectious Diseases (CT/NG Testing, Preimplantation Genetic Testing (PGT), Herpes Simplex Virus (HSV), Hepatitis, Sexually Transmitted Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing), By
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationUnited States Women Health Laboratory Testing Market By Hereditary Cancer (Cervical Cancer, Ovarian Cancer, Breast Cancer), By Reproductive Health and Infectious Diseases (CT/NG Testing, Preimplantation Genetic Testing (PGT), Herpes Simplex Virus (HSV), Hepatitis, Sexually Transmitted Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing), By
According to Global Cancer Observatory, in 2020, around
Additionally, the other factor includes the increasing investments on healthcare sector, major involvement of market players, and increase in number of funding activities. Various initiatives and awareness programs are taken by government or private organizations, to raise awareness about diseases and treatments, as well as information about the availability of more advanced technologies and procedures at healthcare facilities.
Prevalence of Chronic diseases
For instance, an estimated 1,519,907 people in the United States are suffering with leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS) or myeloproliferative neoplasms (MPNs)
Recent Developments
In November 2022, a new molecular diagnostic company namely Roche Holdings launched Cobas 5800 to expand access to PCR testing in the United States. The whole system unit assists in the diagnosis of infectious diseases such as HIV, human papillomavirus, syphilis, sexually transmitted diseases, etc. Additionally, in October 2019, Myriad Genetics, Inc. announced that the U.S. Food and Drug Administration (FDA) approved myChoice CDx for use as a companion diagnostic for Treatment with Zejula in late-line ovarian cancer.
Growing awareness amongst key players of the market
Several market players are getting aware about women health and diseases. Therefore, they are participating in the development of diagnostic procedures for the impressive growth of the market. Also, certain mergers and acquisitions leads to the steady growth of the market. For instance, in February 2022, Laboratory Corporation of America Holdings established a strategic partnership with Ascension to expand its testing capabilities. Additionally, in January 2022, a company namely Your gene Health announced that it has signed a strategic partnership agreement with a point-of-care business namely EKF Diagnostics Holdings plc with accredited laboratory testing capabilities in the U.S.
Market Segmentation
United States Women Health Laboratory Testing Market can be segmented
Market Players
F. Hoffmann-La Roche AG., Stanbio Laboratory L.P., Yourgene Health, Myriad Genetics Inc., Natera, Inc., Ovia Health, Laboratory Corporation of America Holdings, Inc., Gateway Genomics, LLC, Ascension Healthcare Network Inc, EKF Diagnostics Holdings Plc, etc.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2028 |
| Quantitative Units | Revenue in USD Million, Volume Units and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends |
| Segments covered | Hereditary cancer Reproductive health and infectious diseases Prenatal screening and diagnostic testing Region Company |
| Regional scope | Northeast Region, Midwest Region, South Region, West Region |
| Key companies profiled | F. Hoffmann-La Roche AG., Stanbio Laboratory L.P., Yourgene Health, Myriad Genetics Inc., Natera, Inc., Ovia Health, Laboratory Corporation of America Holdings, Inc., Gateway Genomics, LLC, Ascension Healthcare Network Inc, EKF Diagnostics Holdings Plc |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy